Ken Griffin Pulmonx Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 400 shares of LUNG stock, worth $2,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 1,200
66.67%
Holding current value
$2,944
Previous $11,000
81.82%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LUNG
# of Institutions
119Shares Held
29.8MCall Options Held
400Put Options Held
0-
Primecap Management CO Pasadena, CA5.71MShares$42 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.47MShares$25.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$19.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M1.29MShares$9.52 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $274M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...